Found: 54
Select item for more details and to access through your institution.
Genomic studies of multiple myeloma reveal an association between X chromosome alterations and genomic profile complexity.
- Published in:
- Genes, Chromosomes & Cancer, 2017, v. 56, n. 1, p. 18, doi. 10.1002/gcc.22397
- By:
- Publication type:
- Article
Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practice.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 6, p. 575, doi. 10.1002/ajh.24351
- By:
- Publication type:
- Article
Immunomodulatory Effects of the Agaricus blazei Murrill-Based Mushroom Extract AndoSan in Patients with Multiple Myeloma Undergoing High Dose Chemotherapy and Autologous Stem Cell Transplantation: A Randomized, Double Blinded Clinical Study.
- Published in:
- BioMed Research International, 2015, v. 2015, p. 1, doi. 10.1155/2015/718539
- By:
- Publication type:
- Article
Radiotheranostic Agents in Hematological Malignancies.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.911080
- By:
- Publication type:
- Article
A First Report on [<sup>18</sup>F]FPRGD<sub>2</sub> PET/CT Imaging in Multiple Myeloma.
- Published in:
- Contrast Media & Molecular Imaging, 2017, v. 2017, p. 1, doi. 10.1155/2017/6162845
- By:
- Publication type:
- Article
Thymosin β4 in multiple myeloma: friend or foe.
- Published in:
- Annals of the New York Academy of Sciences, 2010, v. 1194, n. 1, p. 125, doi. 10.1111/j.1749-6632.2010.05470.x
- By:
- Publication type:
- Article
The Effects of Forodesine in Murine and Human Multiple Myeloma Cells.
- Published in:
- Advances in Hematology, 2010, v. 2010, p. 1, doi. 10.1155/2010/131895
- By:
- Publication type:
- Article
Contribution of Capillary Zone Electrophoresis Hyphenated with Drift Tube Ion Mobility Mass Spectrometry as a Complementary Tool to Microfluidic Reversed Phase Liquid Chromatography for Antigen Discovery.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 21, p. 13350, doi. 10.3390/ijms232113350
- By:
- Publication type:
- Article
Prognostic value of visual IMPeTUs criteria and metabolic tumor burden at baseline [<sup>18</sup>F]FDG PET/CT in patients with newly diagnosed multiple myeloma.
- Published in:
- EJNMMI Research, 2024, v. 14, n. 1, p. 1, doi. 10.1186/s13550-024-01113-6
- By:
- Publication type:
- Article
P-220: Use of Carfilzomib regimens in patients with Multiple Myeloma refractory to CD38 antibodies: a subgroup analysis from a prospective observational study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S160, doi. 10.1016/S2152-2650(21)02347-8
- By:
- Publication type:
- Article
P-162: Compass: a prospective study comparing clinical evaluation with different geriatric screening methods in newly diagnosed elderly multiple myeloma patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S124, doi. 10.1016/S2152-2650(21)02289-8
- By:
- Publication type:
- Article
OAB-044: Anti-CD38 nanobodies as theranostic agents for multiple myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S28, doi. 10.1016/S2152-2650(21)02118-2
- By:
- Publication type:
- Article
A Noninterventional, Observational, European Post-Authorization Safety Study of Patients With Relapsed/Refractory Multiple Myeloma Treated With Lenalidomide.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Real-World Evidence of the Use of Carfilzomib and Dexamethasone According to Age Subgroup: An Interim Analysis From a Prospective Observational Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e282, doi. 10.1016/j.clml.2019.09.465
- By:
- Publication type:
- Article
Real-World Use of Carfilzomib Therapy Among Patients With Existing Cardiovascular Medical History: An Analysis of a Prospective Observational Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e281, doi. 10.1016/j.clml.2019.09.464
- By:
- Publication type:
- Article
The first-in-class BMI-1 modulators PTC-028 and PTC596 display potent activity in pre-clinical models of multiple myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e113, doi. 10.1016/j.clml.2019.09.188
- By:
- Publication type:
- Article
European Post-Approval Safety Study (EU Pass) of Relapsed/Refractory Multiple Myeloma (RRMM): Safety, Including Second Primary Malignancies, in a Large Cohort of Patients (Pts) Treated With Lenalidomide (LEN), Thalidomide (THAL), and Bortezomib (BORT).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e65, doi. 10.1016/j.clml.2017.03.118
- By:
- Publication type:
- Article
Impfempfehlungen beim Multiplen Myelom: ein Konsensbericht des European Myeloma Network.
- Published in:
- Kompass Onkologie, 2022, v. 9, n. 1, p. 3, doi. 10.1159/000522451
- By:
- Publication type:
- Article
Extramedullary disease in multiple myeloma: a systematic literature review.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 3, p. 1, doi. 10.1038/s41408-022-00643-3
- By:
- Publication type:
- Article
Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 12, p. 1, doi. 10.1038/s41408-021-00587-0
- By:
- Publication type:
- Article
Methylglyoxal, a glycolysis metabolite, triggers metastasis through MEK/ERK/SMAD1 pathway activation in breast cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Patient selection for CAR T or BiTE therapy in multiple myeloma: Which treatment for each patient?
- Published in:
- Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01296-2
- By:
- Publication type:
- Article
A non-internalised CD38-binding radiolabelled single-domain antibody fragment to monitor and treat multiple myeloma.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01171-6
- By:
- Publication type:
- Article
A novel mutation in the CUB sequence of matriptase-2 ( TMPRSS6) is implicated in iron-resistant iron deficiency anaemia (IRIDA).
- Published in:
- British Journal of Haematology, 2013, v. 160, n. 4, p. 564, doi. 10.1111/bjh.12147
- By:
- Publication type:
- Article
Enteroviral meningoencephalitis as complication of Rituximab therapy in a patient treated for diffuse large B-cell lymphoma.
- Published in:
- 2010
- By:
- Publication type:
- Letter
The involvement of osteopontin and its receptors in multiple myeloma cell survival, migration and invasion in the murine 5T33MM model.
- Published in:
- British Journal of Haematology, 2006, v. 132, n. 4, p. 469, doi. 10.1111/j.1365-2141.2005.05886.x
- By:
- Publication type:
- Article
Bone mass of the calvarium.
- Published in:
- 2013
- By:
- Publication type:
- Editorial
Bone mass of the calvarium.
- Published in:
- 2013
- By:
- Publication type:
- Editorial
Real‐world use of carfilzomib combined with lenalidomide and dexamethasone in patients with multiple myeloma in Europe and Israel.
- Published in:
- EJHaem, 2023, v. 4, n. 1, p. 174, doi. 10.1002/jha2.595
- By:
- Publication type:
- Article
The Changing Landscape of Smoldering Multiple Myeloma: A European Perspective.
- Published in:
- Oncologist, 2016, v. 21, n. 3, p. 333, doi. 10.1634/theoncologist.2015-0303
- By:
- Publication type:
- Article
Haematological and molecular responses in refractory anaemia with ring sideroblasts and thrombocytosis treated with lenalidomide.
- Published in:
- European Journal of Haematology, 2014, v. 92, n. 2, p. 179, doi. 10.1111/ejh.12233
- By:
- Publication type:
- Article
Diffuse xanthomatosis as a presenting feature of multiple myeloma.
- Published in:
- European Journal of Haematology, 2010, v. 84, n. 5, p. 460, doi. 10.1111/j.1600-0609.2009.01400.x
- By:
- Publication type:
- Article
Multiple myeloma – an update on diagnosis and treatment.
- Published in:
- European Journal of Haematology, 2008, v. 81, n. 5, p. 329, doi. 10.1111/j.1600-0609.2008.01127.x
- By:
- Publication type:
- Article
Establishment of a Murine Graft-versus-Myeloma Model Using Allogeneic Stem Cell Transplantation.
- Published in:
- PLoS ONE, 2014, v. 9, n. 11, p. 1, doi. 10.1371/journal.pone.0113764
- By:
- Publication type:
- Article
Mithramycin Exerts an Anti-Myeloma Effect and Displays Anti-Angiogenic Effects through Up-Regulation of Anti-Angiogenic Factors
- Published in:
- PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0062818
- By:
- Publication type:
- Article
A Novel Mouse Model for Multiple Myeloma (MOPC315.BM) That Allows Noninvasive Spatiotemporal Detection of Osteolytic Disease.
- Published in:
- PLoS ONE, 2012, v. 7, n. 12, p. 1, doi. 10.1371/journal.pone.0051892
- By:
- Publication type:
- Article
Serological response to SARS‐CoV‐2 mRNA‐containing lipid nanoparticle vaccine in patients with multiple myeloma: A negative impact of CD38<sup>+</sup> regulatory T cells?
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 4, p. 391, doi. 10.1111/bjh.18110
- By:
- Publication type:
- Article
Expert review on soft‐tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 3, p. 496, doi. 10.1111/bjh.17338
- By:
- Publication type:
- Article
The anti‐mitotic agents PTC‐028 and PTC596 display potent activity in pre‐clinical models of multiple myeloma but challenge the role of BMI‐1 as an essential tumour gene.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 6, p. 877, doi. 10.1111/bjh.16595
- By:
- Publication type:
- Article
Mass cytometry in POEMS (polyneuropathy, organomegaly, endocrinopathy, M‐protein, skin changes) syndrome: looking for a needle in a haystack.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 1, p. 16, doi. 10.1111/bjh.16554
- By:
- Publication type:
- Article
Correction to: MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents.
- Published in:
- Journal of Hematology & Oncology, 2020, v. 13, n. 1, p. 1, doi. 10.1186/s13045-020-01007-9
- By:
- Publication type:
- Article
High serum ferritin levels in newly diagnosed patients with myelodysplastic syndromes are associated with greater symptom severity.
- Published in:
- International Journal of Hematology, 2020, v. 112, n. 2, p. 141, doi. 10.1007/s12185-020-02920-y
- By:
- Publication type:
- Article
Biological aspects of angiogenesis in multiple myeloma.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Impact of the immunomodulating peptide thymosin alpha 1 on multiple myeloma and immune recovery after hematopoietic stem cell transplantation.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 8, p. 989, doi. 10.1007/s00262-015-1708-2
- By:
- Publication type:
- Article
Real-World Use and Effectiveness of Carfilzomib Plus Dexamethasone in Relapsed/Refractory Multiple Myeloma in Europe.
- Published in:
- Cancers, 2022, v. 14, n. 21, p. 5311, doi. 10.3390/cancers14215311
- By:
- Publication type:
- Article
Balancing the CD38 Expression on Effector and Target Cells in Daratumumab-Mediated NK Cell ADCC against Multiple Myeloma.
- Published in:
- Cancers, 2021, v. 13, n. 12, p. 3072, doi. 10.3390/cancers13123072
- By:
- Publication type:
- Article
Emerging Therapeutic Strategies to Overcome Drug Resistance in Multiple Myeloma.
- Published in:
- Cancers, 2021, v. 13, n. 7, p. 1686, doi. 10.3390/cancers13071686
- By:
- Publication type:
- Article
The Road to a Cure: Emerging Treatments for Multiple Myeloma.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Loss of Stromal Galectin-1 Enhances Multiple Myeloma Development: Emphasis on a Role in Osteoclasts.
- Published in:
- Cancers, 2019, v. 11, n. 2, p. 261, doi. 10.3390/cancers11020261
- By:
- Publication type:
- Article